Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jayamas Medica Industri Tbk. (OMED) vs Reksa Dana Indeks Premier ETF FTSE Indonesia ESG (XIFE) Price & Performance

Jayamas Medica Industri Tbk.Trade
Reksa Dana Indeks Premier ETF FTSE Indonesia ESGTrade

Price performance (Past 24H)

Key statistics

Jayamas Medica Industri Tbk. vs Reksa Dana Indeks Premier ETF FTSE Indonesia ESG — how do they compare? Jayamas Medica Industri Tbk. trades at Rp226 (market cap 6.33T, 17.41M 24h volume), while Reksa Dana Indeks Premier ETF FTSE Indonesia ESG trades at Rp92 (market cap 28.06B, 9.8K 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 225.6× Reksa Dana Indeks Premier ETF FTSE Indonesia ESG's market cap, and Jayamas Medica Industri Tbk. is more actively traded (17.41M versus 9.8K). Which is the better fit depends on your goals.

OMEDXIFE
Market Cap
6.33T28.06B
Volume
17.41M9.8K
Lot
174.13K98
Turnover
3.92B908.2K
Average Price
225.2892.67
Value
3.92B908.2K
Indicative Equilibrium Price
226
Indicative Equilibrium Volume
51.45K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OMED
View details

About Jayamas Medica Industri Tbk.

PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.

Read more on OMED

About Reksa Dana Indeks Premier ETF FTSE Indonesia ESG

Read more on XIFE